Ribavirin plus interferon versus interferon for chronic hepatitis C

Jesper Brok; Lise Lotte Gluud; Christian Gluud

doi:10.1002/14651858.CD005445.pub2

Ribavirin plus interferon versus interferon for chronic hepatitis C

Jesper Brok, Lise Lotte Gluud, Christian Gluud

Copenhagen Trial Unit Rigshospitalet

40 Citationer (Scopus)

Abstract

Hepatitis C is a major cause of liver-related morbidity and mortality. Standard therapy is ribavirin plus pegylated interferon to achieve undetectable level of virus in the blood, but the effect on clinical outcomes is controversial.

Originalsprog	Engelsk
Tidsskrift	Cochrane Database of Systematic Reviews
Udgave nummer	1
Sider (fra-til)	CD005445
ISSN	1469-493X
DOI	https://doi.org/10.1002/14651858.CD005445.pub2
Status	Udgivet - 1 jan. 2010

Adgang til dokumentet

10.1002/14651858.CD005445.pub2

Citationsformater

@article{09003c18c2ea4494a0f32427953e2890,

title = "Ribavirin plus interferon versus interferon for chronic hepatitis C",

abstract = "Hepatitis C is a major cause of liver-related morbidity and mortality. Standard therapy is ribavirin plus pegylated interferon to achieve undetectable level of virus in the blood, but the effect on clinical outcomes is controversial.",

author = "Jesper Brok and Gluud, {Lise Lotte} and Christian Gluud",

year = "2010",

month = jan,

day = "1",

doi = "10.1002/14651858.CD005445.pub2",

language = "English",

pages = "CD005445",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "John Wiley and Sons Ltd",

number = "1",

}

TY - JOUR

T1 - Ribavirin plus interferon versus interferon for chronic hepatitis C

AU - Brok, Jesper

AU - Gluud, Lise Lotte

AU - Gluud, Christian

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Hepatitis C is a major cause of liver-related morbidity and mortality. Standard therapy is ribavirin plus pegylated interferon to achieve undetectable level of virus in the blood, but the effect on clinical outcomes is controversial.

AB - Hepatitis C is a major cause of liver-related morbidity and mortality. Standard therapy is ribavirin plus pegylated interferon to achieve undetectable level of virus in the blood, but the effect on clinical outcomes is controversial.

U2 - 10.1002/14651858.CD005445.pub2

DO - 10.1002/14651858.CD005445.pub2

M3 - Journal article

C2 - 20091577

SN - 1469-493X

SP - CD005445

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 1

ER -

Ribavirin plus interferon versus interferon for chronic hepatitis C

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater